For instance, CAR-NK cells targeting human epidermal growth factor receptor 2 (HER2) in OC models demonstrated robust tumor regression via dual mechanisms: direct cytolytic activity and interferon-γ (IFN-γ)-mediated TME remodeling (21). The gene discussed is ERBB2; the disease is neoplasm.